NCT03341078View on ClinicalTrials.gov

Pilot Study of the Effect of Ibudilast on Neuroinflammation in Methamphetamine Users

PHASE2RecruitingINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

May 1, 2019

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Methamphetamine-dependence
Interventions
DRUG

Ibudilast

Ibudilast capsules will be orally ingested twice daily for 6 weeks.

DRUG

Placebo Oral Tablet

Placebo capsules will be orally ingested twice daily for 6 weeks.

Trial Locations (1)

97207-2964

RECRUITING

VA Portland Health Care System, Portland, OR, Portland

All Listed Sponsors
collaborator

Portland VA Medical Center

FED

collaborator

Oregon Health and Science University

OTHER

lead

VA Office of Research and Development

FED